https://www.selleckchem.com/pr....oducts/bms-345541.ht
Testosterone replacement therapy (TRT) is commonly used for various causes of androgen deficiency and subsidized by the Pharmaceutical Benefits Scheme (PBS) in Australia when appropriate. In response to a sharp increase in the prescribing of subsidized TRT, the Australian government instituted new, stricter prescription criteria in April 2015. We aim to demonstrate longitudinal changes in the prescription patterns of subsidized TRT over time. The publicly available PBS database was accessed for TRT prescription data between 1992-2018
Like
Comment
Share
